- Home
- DSX vs BDTX Comparison
DSX vs BDTX Comparison
Compare DSX & BDTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- DSX
- BDTX
- Stock Information
- Founded
- DSX 1999
- BDTX 2014
- Country
- DSX Greece
- BDTX United States
- Employees
- DSX N/A
- BDTX N/A
- Industry
- DSX Marine Transportation
- BDTX Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- DSX Consumer Discretionary
- BDTX Health Care
- Exchange
- DSX Nasdaq
- BDTX Nasdaq
- Market Cap
- DSX 189.9M
- BDTX 181.4M
- IPO Year
- DSX 2005
- BDTX 2020
- Fundamental
- Price
- DSX $1.69
- BDTX $3.96
- Analyst Decision
- DSX
- BDTX Strong Buy
- Analyst Count
- DSX 0
- BDTX 5
- Target Price
- DSX N/A
- BDTX $12.00
- AVG Volume (30 Days)
- DSX 338.5K
- BDTX 1.0M
- Earning Date
- DSX 11-24-2025
- BDTX 11-04-2025
- Dividend Yield
- DSX 2.35%
- BDTX N/A
- EPS Growth
- DSX 49.38
- BDTX N/A
- EPS
- DSX 0.12
- BDTX 0.25
- Revenue
- DSX $224,186,000.00
- BDTX $70,000,000.00
- Revenue This Year
- DSX N/A
- BDTX N/A
- Revenue Next Year
- DSX $10.87
- BDTX N/A
- P/E Ratio
- DSX $14.32
- BDTX $15.62
- Revenue Growth
- DSX N/A
- BDTX N/A
- 52 Week Low
- DSX $1.27
- BDTX $1.20
- 52 Week High
- DSX $2.53
- BDTX $4.03
- Technical
- Relative Strength Index (RSI)
- DSX 48.26
- BDTX 69.63
- Support Level
- DSX $1.69
- BDTX $3.81
- Resistance Level
- DSX $1.82
- BDTX $4.03
- Average True Range (ATR)
- DSX 0.07
- BDTX 0.20
- MACD
- DSX -0.02
- BDTX 0.04
- Stochastic Oscillator
- DSX 31.28
- BDTX 91.58
About DSX Diana Shipping inc. common stock
Diana Shipping Inc provides shipping transportation services. The company, through its subsidiaries, operates a fleet of vessels consisting of dry bulk carriers such as Panamax, Kamsarmax, Post-Panamax, Capesize and Newcastlemax vessels. Using this fleet, the firm provides transportation services for various goods including coal, iron ore, and grains. It also transports minor bulks, including steel products, cement, and fertilizers through its dry bulk carrier vessels. The operation of the vessels is the main source of revenue generation, the services provided by the vessels are similar and all operate under the same economic environment.
About BDTX Black Diamond Therapeutics Inc.
Black Diamond Therapeutics Inc is a clinical-stage oncology company developing MasterKey therapies that target families of oncogenic mutations in patients with cancer. It is engaged in the discovery and development of small molecule, tumor-agnostic therapies. The company has one pipeline technology platform, namely Mutation-Allostery-Pharmacology, which is targeting mutations in cancer. Its drugs under the pipeline are BDTX-4933 and BDTX-1535.